In patients with IBD, transcriptomic profiling of whole blood revealed CD177 as the most differentially expressed gene, with levels correlating positively with endoscopic activity, suggesting its potential as a biomarker of intestinal inflammation [274]. This evidence concerns the gene CD177 and irritable bowel syndrome.